Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04305249 |
| Title | Safety and Preliminary Efficacy of ATG-017 Monotherapy in Advanced Solid Tumors and Hematological Malignancies (ERASER) |
| Acronym | ERASER |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Antengene Therapeutics Limited |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |